Concentrix
CNXC
26.16
+1.32
+5.31%
Concentrix
US · CNXC
#2960 by market cap
Listed 2015
26.16
+1.32
+5.31%
Live - 5344 symbols - heartbeat 68s ago
· 2026-10-08 08:38
Pre-market
25.99
-0.66%
After-hours
26.16
0.00%
- Market cap
- 1.60B
- P/E (TTM)i
- -0.68
- P/Bi
- 0.90
- EPSi
- -20.36
- Div yieldi
- 5.50%
- 52W posi
- 27%
Reader sentiment
Are you bullish or bearish on CNXC?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.30, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +2.15% YoY
Margins
- Gross margin
- 34.96%
- Operating margin
- 6.20%
- Net margin
- -13.06%
Key ratios & quality
- Enterprise valuei
- 5.91B
- Altman Z-Scorei
- 1.30
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.46B | 4.71B | 4.72B | 5.59B | 6.32B | 7.11B | 9.62B | 9.83B |
| Gross profit | 937.55M | 1.75B | 1.66B | 1.97B | 2.26B | 2.58B | 3.45B | 3.44B |
| Selling & admin expenses | 792.79M | 1.45B | 1.35B | 1.40B | 1.62B | 1.92B | 2.85B | 2.83B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 144.76M | 294.33M | 308.76M | 572.40M | 640.19M | 661.33M | 596.39M | 609.54M |
| Pretax profit | 110.91M | 204.42M | 267.90M | 555.70M | 605.00M | 408.23M | 299.27M | -1.18B |
| Tax | 62.64M | 87.25M | 103.08M | 150.12M | 169.36M | 94.39M | 48.06M | 96.70M |
| Net profit | 48.27M | 117.16M | 164.81M | 405.58M | 435.64M | 313.84M | 251.22M | -1.28B |
| Basic EPS | 1 | 2 | 3 | 8 | 8 | 6 | 4 | -20 |
| Diluted EPS | 0.93 | 2.27 | 3.19 | 7.70 | 8.28 | 5.70 | 3.71 | -20.36 |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Revenue | 2.42B | 2.48B | 2.55B | 2.50B | 2.46B | 2.45B |
| Gross profit | 848.15M | 855.01M | 875.96M | 849.66M | 823.35M | 848.88M |
| Selling & admin expenses | 699.80M | 708.02M | 730.61M | 731.10M | 727.93M | 709.18M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 148.35M | 146.98M | 145.35M | 118.56M | 95.42M | 139.70M |
| Pretax profit | 51.72M | 111.44M | -1.45B | 28.73M | 69.48M | -979.76M |
| Tax | 9.63M | 23.33M | 33.21M | 7.14M | 14.20M | 8.35M |
| Net profit | 42.09M | 88.11M | -1.48B | 21.59M | 55.28M | -988.11M |
| Basic EPS | 1 | 1 | -24 | 0 | 1 | -16 |
| Diluted EPS | 0.63 | 1.34 | -23.85 | 0.33 | 0.86 | -16.24 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.30B | 1.30B | 1.42B | 1.54B | 1.75B | 2.86B | 2.84B | 3.08B |
| Cash & ST investments | 123.39M | 79.66M | 152.66M | 182.04M | 145.38M | 295.34M | 240.57M | 327.35M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 4.77B | 4.65B | 5.18B | 5.05B | 6.67B | 12.49B | 11.99B | 10.76B |
| Total current liabilities | 3.01B | 2.70B | 1.01B | 968.21M | 1.13B | 2.07B | 2.00B | 2.20B |
| Short-term debt | 2.24B | 1.98B | 33.75M | -- | -- | 2.31M | 2.52M | 65.63M |
| Long-term debt | -- | -- | 1.11B | 802.02M | 2.22B | 4.94B | 4.73B | 4.57B |
| Total liabilities | 3,447,191,000.00 | 3,183,914,000.00 | 2,875,471,000.00 | 2,426,112,000.00 | 3,973,864,000.00 | 8,348,533,000.00 | 7,951,714,000.00 | 8,016,741,000.00 |
| Total equity | 1.32B | 1.47B | 2.30B | 2.62B | 2.70B | 4.14B | 4.04B | 2.74B |
| Retained earnings | -- | -- | 0 | 392.50M | 774.11M | 1.02B | 1.19B | -177.01M |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Total current assets | 3.17B | 3.14B | 3.08B | 3.04B | 3.04B | 2.92B |
| Cash & ST investments | 342.76M | 350.26M | 327.35M | 222.70M | 255.57M | 244.69M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 12.40B | 12.41B | 10.76B | 10.67B | 10.51B | 9.26B |
| Total current liabilities | 1.97B | 2.01B | 2.20B | 2.58B | 2.58B | 2.37B |
| Short-term debt | 28.33M | 37.50M | 65.63M | 750.00M | 650.00M | 450.00M |
| Long-term debt | 4.86B | 4.79B | 4.57B | 4.00B | 3.93B | 3.93B |
| Total liabilities | 8,117,360,000.00 | 8,065,970,000.00 | 8,016,741,000.00 | 7,886,208,000.00 | 7,811,561,000.00 | 7,492,030,000.00 |
| Total equity | 4.28B | 4.34B | 2.74B | 2.79B | 2.70B | 1.77B |
| Retained earnings | 1.26B | 1.33B | -177.01M | -178.65M | -146.52M | -1.16B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 212.32M | 449.74M | 507.61M | 514.18M | 600.72M | 678.01M | 667.49M | 806.97M |
| Depreciation & amortization | 154.60M | 305.78M | 276.57M | 277.18M | 309.54M | 388.30M | 705.85M | 660.43M |
| Free cash flow | 119.81M | 338.61M | 336.28M | 365.10M | 460.70M | 497.48M | 428.73M | 572.47M |
| Dividends paid | -- | 0 | 0 | -13.08M | -53.43M | -63.50M | -83.81M | -89.62M |
| Stock buybacks / issuance | -- | 0 | 0 | -57.49M | -133.29M | -81.19M | -149.48M | -188.71M |
| Ending cash balance | 127.88M | 83.51M | 156.35M | 183.01M | 157.46M | 516.49M | 429.60M | 521.13M |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Operating cash flow | 236.54M | 224.80M | 344.22M | -83.22M | 257.89M | -- |
| Depreciation & amortization | 165.31M | 168.56M | 165.85M | 159.37M | 160.12M | -- |
| Free cash flow | 180.74M | 159.75M | 281.19M | -137.12M | 209.72M | -- |
| Dividends paid | -22.14M | -21.87M | -23.23M | -23.15M | -23.07M | -- |
| Stock buybacks / issuance | -46.82M | -41.77M | -72.20M | -45.89M | -1.29M | -- |
| Ending cash balance | 535.13M | 538.49M | 521.13M | 415.51M | 441.49M | -- |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 3.66 | 8.40 | 8.74 | 16.48 | 16.37 | 9.18 | 5.91 | -37.82 |
| ROA %i | 1.01 | 2.49 | 3.35 | 7.93 | 7.43 | 3.28 | 1.97 | -11.28 |
| ROIC %i | 2.14 | 5.26 | 4.86 | 12.36 | 11.64 | 6.69 | 5.73 | -13.21 |
| 5-year avg ROE %i | -- | -- | -- | -- | 10.68 | 11.75 | 11.25 | 1.94 |
| EBIT margin %i | 6.06 | 6.30 | 6.70 | 10.36 | 10.67 | 8.56 | 6.46 | -9.08 |
| FCF / sales %i | 4.86 | 7.19 | 7.13 | 6.53 | 7.28 | 6.99 | 4.46 | 5.83 |
| Current ratioi | 0.43 | 0.48 | 1.41 | 1.59 | 1.55 | 1.38 | 1.42 | 1.40 |
| Quick ratioi | 0.37 | 0.41 | 1.22 | 1.44 | 1.36 | 1.05 | 1.09 | 1.06 |
| Debt / assetsi | 47.05 | 42.58 | 22.12 | 15.89 | 33.35 | 39.56 | 39.49 | 43.10 |
| LT debt / equityi | -- | -- | 48.28 | 30.61 | 82.51 | 119.22 | 117.16 | 166.63 |
| Interest coveragei | 3.90 | 3.22 | 6.54 | 25.11 | 9.63 | 3.03 | 1.93 | -3.07 |
| Revenue CAGR (3Y) %i | -- | -- | 33.35 | 31.39 | 10.34 | 14.66 | 19.85 | 15.82 |
| Net income CAGR (3Y) %i | -- | -- | 31.64 | 103.30 | 54.85 | 23.95 | -14.76 | -- |
| FCF CAGR (3Y) %i | -- | -- | 55.37 | 44.98 | 10.81 | 13.94 | 5.50 | 7.51 |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| ROE %i | 5.60 | 7.20 | -37.82 | -38.97 | -37.73 | -78.35 |
| ROA %i | 1.91 | 2.49 | -11.28 | -11.78 | -11.50 | -22.10 |
| ROIC %i | 5.39 | 6.09 | -13.21 | -14.01 | -13.93 | -29.09 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 6.20 | 6.93 | -9.08 | -9.66 | -9.51 | -20.56 |
| FCF / sales %i | 5.04 | 5.31 | 5.83 | 4.87 | 5.14 | -- |
| Current ratioi | 1.61 | 1.56 | 1.40 | 1.18 | 1.18 | 1.23 |
| Quick ratioi | 1.22 | 1.20 | 1.06 | 0.88 | 0.87 | 0.93 |
| Debt / assetsi | 39.45 | 38.90 | 43.10 | 44.45 | 43.61 | 47.25 |
| LT debt / equityi | 113.64 | 110.27 | 166.63 | 143.28 | 145.67 | 221.93 |
| Interest coveragei | 1.96 | 2.27 | -3.07 | -3.29 | -3.33 | -7.37 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 08:38:02 · For reference only, not investment advice and not tailored to your situation.